MOUNTAIN VIEW, Calif., Sept. 30, 2008 (GLOBE NEWSWIRE) -- Pharsight Corporation (Nasdaq:PHST), a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug development, today announced that Samer Mouksassi, Pharm.D., associate scientist, Pharsight Reporting and Analysis Services, has been invited to speak to clinical and pharmacological scientists attending the 2nd World Conference on Magic Bullets (Ehrlich II). The Ehrlich II Conference will be held at the Georg-Simon-Ohm University for Applied Sciences in Nurnberg, Germany from October 3-5, 2008. Dr. Mouksassi will present at the conference plenary session on October 3.
